The YML009W-B Antibody (Product Code: CSB-PA715288XA01SVG) is a custom polyclonal antibody developed for research applications targeting the protein encoded by the YML009W-B gene in Saccharomyces cerevisiae (Baker’s yeast). This antibody is cataloged under UniProt accession number Q6B0Y1 and is available in two sizes (0.1 ml and 1.0 ml) . Antibodies like YML009W-B are critical tools for studying gene function, protein localization, and molecular interactions in yeast models, which are widely used to understand eukaryotic cellular processes .
The YML009W-B gene resides on chromosome XIII of S. cerevisiae. While functional annotations for this specific protein remain limited, yeast gene nomenclature (YML = Yeast Middle Left arm) suggests its chromosomal location. The encoded protein is hypothetical, with no explicit functional domains identified in the provided data. Antibodies like YML009W-B enable researchers to empirically investigate its role in cellular pathways, such as metabolism or stress response, through techniques like knockout studies or protein interaction mapping .
Protein Localization: Antibodies against yeast proteins are frequently used to determine subcellular localization via immunofluorescence . For YML009W-B, this could clarify whether the protein is membrane-bound, cytoplasmic, or nuclear.
Interaction Networks: Co-immunoprecipitation (Co-IP) paired with mass spectrometry could identify binding partners, elucidating its role in macromolecular complexes .
Specificity: Antibodies are typically validated using knockout strains (e.g., comparing wild-type vs. YML009W-BΔ lysates) to confirm signal absence in null mutants .
Cross-Reactivity: As a polyclonal antibody, YML009W-B may exhibit off-target binding; rigorous validation against related yeast strains is advised .
Studies on analogous antibodies (e.g., anti-CHIKV or anti-SARS-CoV-2 monoclonal antibodies) highlight the importance of epitope mapping and neutralization assays . While YML009W-B is not therapeutic, its development follows similar principles of antigen design and host immunization .
Functional Annotation: Further studies are needed to characterize the YML009W-B protein’s biological role.
Therapeutic Potential: Unlike monoclonal antibodies targeting human pathogens (e.g., Epstein-Barr virus or SARS-CoV-2 ), YML009W-B remains confined to basic research.
Cusabio. Custom Antibodies for Sale, Gene Name Starting with Y Page 27. Accessed March 13, 2025.
Britannica. Antibody | Definition, Structure, Function, & Types. March 7, 2025.
NIH. Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus. October 27, 2022.
Abcam. Anti-ProCathepsin B Antibody [EPR24353-25] (ab270998).
PMC. AbDb: Antibody Structure Database—A Database of PDB-Derived Antibody Structures. April 27, 2018.
bioRxiv. YAbS: The Antibody Society’s Antibody Therapeutics Database. February 10, 2025.
STRING: 4932.YML009W-B
YML009W-B is a genetic element in Saccharomyces cerevisiae that has been identified in studies related to oxidative stress responses . Its significance stems from its potential role in cellular defense mechanisms against reactive oxygen species. Antibodies targeting this protein are valuable tools for investigating stress response pathways, protein localization, and expression levels during oxidative challenges. When designing experiments with YML009W-B antibodies, researchers should consider both the genetic context (such as strain variations) and environmental conditions that might affect protein expression.
Antibody validation requires multiple complementary approaches to ensure specificity:
Western blot analysis comparing wild-type and knockout cell lysates (essential for demonstrating specificity)
Immunoprecipitation followed by mass spectrometry to confirm target capture
Immunofluorescence comparing localization patterns in wild-type versus knockout cells
Cross-reactivity testing against closely related proteins
The YCharOS initiative demonstrates that proper antibody validation should include knockout controls, as the best-performing antibodies show bands only in wild-type samples and not in knockout controls . For yeast proteins like YML009W-B, validation in different strain backgrounds is particularly important to account for genetic variation.
| Experimental Condition | Potential Impact on Detection | Optimization Strategy |
|---|---|---|
| Oxidative stress level | Altered protein expression or modifications | Titrate stress agent (e.g., H₂O₂) and monitor time course |
| Sample preparation | Protein degradation or epitope masking | Include protease inhibitors; optimize lysis buffers |
| Fixation method | Epitope accessibility | Compare paraformaldehyde vs. methanol fixation |
| Genetic background | Strain-specific variations | Include multiple reference strains |
Researchers should note that oxidative stress conditions may induce post-translational modifications in YML009W-B that could affect antibody recognition. Similar to other proteins involved in stress responses, these modifications might include phosphorylation, acetylation, or oxidation of specific residues . Careful optimization of experimental conditions is therefore essential for consistent antibody performance.
Cross-reactivity is a significant concern in antibody-based detection systems, particularly for proteins that share homologous domains. To address this issue:
Perform epitope mapping to identify the specific binding region of the antibody
Conduct competitive binding assays with recombinant proteins
Utilize multiple antibodies targeting different epitopes of YML009W-B
Implement siRNA knockdown or CRISPR knockout controls to verify specificity
The high prevalence of self-reactive antibodies (55-75%) produced during B cell development underscores the importance of rigorous specificity testing. When developing or selecting antibodies for YML009W-B, researchers should consider mapping the exact epitope to ensure it doesn't overlap with conserved regions in related proteins.
ChIP experiments with YML009W-B antibodies require careful optimization:
Crosslinking conditions: Test both formaldehyde (1-3%) and dual crosslinkers (formaldehyde + disuccinimidyl glutarate) for optimal protein-DNA fixation
Chromatin fragmentation: Sonication parameters should be optimized to yield fragments of 200-500 bp
Antibody concentration: Titrate antibody amounts (typically 2-10 μg per ChIP reaction)
Washing stringency: Optimize salt concentration in wash buffers to reduce background while maintaining specific signals
When analyzing ChIP-seq data for YML009W-B, researchers should incorporate controls for regions associated with oxidative stress response, as indicated by studies in yeast showing relationship between oxidative stress tolerance and various genetic elements . The ChIP assay protocol should be similar to that described in oxidative stress research methodologies (B.12.9 Chromatin Immunoprecipitation (ChIP) Assay) .
When interpreting Western blot results for YML009W-B:
Multiple bands may represent post-translational modifications, particularly under oxidative stress
Band intensity changes across different stress conditions may indicate regulation at protein stability level
Mobility shifts may indicate phosphorylation or other modifications
According to YCharOS antibody characterization standards, a selective antibody might display multiple wild-type bands representing truncated splice isoforms, multimers, or post-translationally modified forms of the protein . For YML009W-B specifically, researchers should correlate Western blot patterns with the known stress response pathways in yeast, potentially involving oxidative stress response elements like those regulated by YAP1, which appears in the same context as YML009W-B in the literature .
Investigating protein interactions during oxidative stress response requires multiple complementary approaches:
Co-immunoprecipitation (Co-IP) with YML009W-B antibodies followed by mass spectrometry to identify interaction partners
Proximity ligation assays to visualize interactions in situ
FRET/BRET assays to monitor dynamic interactions in living cells
Reciprocal Co-IP experiments to confirm interactions from both perspectives
Research on oxidative stress tolerance in yeast has revealed complex genetic and molecular mechanisms , suggesting that YML009W-B may participate in protein complexes that respond to reactive oxygen species. When designing Co-IP experiments, researchers should consider the cellular damage control mechanisms for reactive oxygen and nitrogen species (RONS) effects, including proteasomal degradation of oxidized proteins and DNA repair mechanisms .
While specific contradictions regarding YML009W-B are not detailed in the provided search results, research on oxidative stress response in yeast often reveals complex and sometimes contradictory findings about gene function. Antibody-based approaches can help resolve such contradictions through:
Temporal analysis of protein expression and modification patterns during stress response
Subcellular localization studies under different conditions
Interaction network mapping to place YML009W-B in functional pathways
Identification of post-translational modifications that may explain different functional states
Given that YML009W-B appears in research related to oxidative stress tolerance , researchers should consider whether apparent contradictions might reflect strain-specific differences, as illustrated by research showing multiple genetic architectures can lead to similar phenotypic outcomes in stress response .
AI technologies are revolutionizing antibody research and can be applied to YML009W-B studies:
De novo generation of antigen-specific antibody sequences targeting specific YML009W-B epitopes
Prediction of optimal antibody CDRH3 sequences using germline-based templates
Structure-based epitope prediction to identify accessible regions unique to YML009W-B
In silico affinity maturation to improve binding properties
Recent advances in AI-based antibody development have demonstrated efficiency in generating antigen-specific antibodies, as shown by successful application to SARS-CoV-2 targets . These approaches can bypass the complexity of natural antibody generation while achieving similar specificity. For yeast proteins like YML009W-B, computational prediction of antibody-accessible epitopes could significantly improve targeting strategies.
Multiplexed detection involving YML009W-B antibodies requires careful planning:
Select compatible antibodies from different host species to allow simultaneous detection
Use directly conjugated primary antibodies with distinct fluorophores to minimize cross-reactivity
Implement spectral unmixing for fluorescence microscopy to resolve overlapping emission spectra
Include appropriate single-stain controls for accurate compensation
When designing multiplexed experiments to study YML009W-B in the context of oxidative stress response, researchers should consider including markers for proteasome activity and DNA damage, as these are key cellular systems that act as damage control mechanisms for the effects of reactive oxygen and nitrogen species .
Quantitative analysis in high-throughput experiments requires rigorous methodology:
| Analytical Approach | Key Considerations | Normalization Strategy |
|---|---|---|
| Western blot quantification | Linear dynamic range, exposure time | Housekeeping proteins stable under oxidative stress |
| Mass spectrometry | Peptide selection, ionization efficiency | Stable isotope labeling (SILAC) or iBAQ |
| Image-based analysis | Background subtraction, threshold setting | Cell size, number, and morphology |
| Flow cytometry | Gating strategy, fluorophore brightness | Reference populations, beads |
For yeast studies involving YML009W-B, researchers should incorporate appropriate controls that account for the potential influence of aneuploidies, which can be conditionally beneficial in certain stress conditions . Statistical analysis should follow approaches used in quantitative genetics research on stress responses, where chemical treatment is used to induce specific types of stress .
Developing modification-specific antibodies requires special attention to:
Peptide design incorporating the specific modification of interest
Stringent negative control testing against unmodified protein
Validation in biological contexts where the modification is induced or inhibited
Cross-reactivity testing against similar modifications on related proteins
For YML009W-B, which appears in oxidative stress research contexts , potential modifications might include oxidation of cysteine residues, phosphorylation at stress-responsive sites, or ubiquitination related to protein quality control during stress. Researchers developing modification-specific antibodies should consider the dynamic nature of these modifications during stress response and recovery phases.
Single-cell analysis with YML009W-B antibodies can reveal important insights:
Mass cytometry (CyTOF) using metal-conjugated antibodies can quantify YML009W-B alongside dozens of other markers
Single-cell Western blot techniques enable protein quantification in individual cells
Imaging mass cytometry can map YML009W-B localization within tissue context
Microfluidic techniques can correlate YML009W-B levels with single-cell transcriptomics
Stress response heterogeneity is an important consideration in yeast populations, as indicated by research showing that multiple genetic architectures can lead to similar phenotypic outcomes in stress response . Single-cell approaches can help determine whether YML009W-B expression or modification patterns contribute to this heterogeneity.
Emerging technologies for antibody improvement include:
AI-based antibody sequence optimization targeting YML009W-B-specific epitopes
Nanobody and single-domain antibody development for improved accessibility to structural epitopes
Recombinant antibody engineering with site-specific modifications to enhance stability
Proximity-based labeling combined with antibody detection for enhanced specificity
Recent advances in AI-based technology for de novo generation of antigen-specific antibody CDRH3 sequences using germline-based templates demonstrate how computational approaches can complement traditional antibody development methods . These technologies could potentially be applied to generate highly specific antibodies against YML009W-B or its modified forms.